Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
CASE STUDY
'A Pharmaceutical Company Would Never Do This' STU BORMAN, C&EN WASHINGTON
At the University of Pittsburgh, researchers have been working on a combinatorial project that drug firms would consider too much of a gamble, according to the project's principal investigator, chemistry professor Peter Wipf. He described the project--the pursuit of analogs of the natural product curacin A as potential anticancer lead compounds--at the recent ACS ProSpectives conference on combinatorial chemistry.----->
http://pubs.acs.org/cen/coverstory/8045/8045combinatorial1b.html

;o)
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement